The selective COX-2 inhibitors have the following advantage(*) over the nonselective NSAIDs:
A. They are less likely to cause gastric ulcers and their complications
B. They are likely to be more effective in rheumatoid arthritis
C. They are not likely to produce renal complications
D. All of the above
